Peter answered that question stating that GSK will have protection for usage on ACS but who is going to stop the pharmacist from giving the generic version. As far as pharmacist is concerned, they are concerned on the medication and GSK can't sue the doctors for fear of them not recommending GSK product.
- Forums
- ASX - By Stock
- TSN
- brisbane presentation
TSN
the sustainable nutrition group ltd
Add to My Watchlist
0.00%
!
1.0¢

brisbane presentation, page-23
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online